These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 8382247)

  • 21. Differential cholera-toxin- and pertussis-toxin-catalysed ADP-ribosylation of G-proteins coupled to formyl-peptide and leukotriene B4 receptors.
    Schepers TM; McLeish KR
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):469-73. PubMed ID: 8380997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential activation of dibutyryl cAMP-differentiated HL-60 human leukemia cells by chemoattractants.
    Klinker JF; Schwaner I; Offermanns S; Hagelüken A; Seifert R
    Biochem Pharmacol; 1994 Nov; 48(10):1857-64. PubMed ID: 7986196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receptor-stimulated dissociation of GTP[S] from Gi-proteins in membranes of HL-60 cells.
    Kupprion C; Wieland T; Jakobs KH
    Cell Signal; 1993 Jul; 5(4):425-33. PubMed ID: 8373724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoattractant receptor-specific differences in G protein activation rates regulate effector enzyme and functional responses.
    Jacobs AA; Huber JL; Ward RA; Klein JB; McLeish KR
    J Leukoc Biol; 1995 Apr; 57(4):679-86. PubMed ID: 7722425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid differentiated HL-60 cells display specific leukotriene B4 binding sites.
    Gorman RR; Ruppel PL; Benjamin CW
    Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():165-77. PubMed ID: 3028094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of Gi-mediated phospholipase C activation by retinoic acid in HL-60 cells. Possible role of G gamma 2.
    Iiri T; Homma Y; Ohoka Y; Robishaw JD; Katada T; Bourne HR
    J Biol Chem; 1995 Mar; 270(11):5901-8. PubMed ID: 7890721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Farnesylcysteine analogues inhibit chemotactic peptide receptor-mediated G-protein activation in human HL-60 granulocyte membranes.
    Scheer A; Gierschik P
    FEBS Lett; 1993 Mar; 319(1-2):110-4. PubMed ID: 8454040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of nucleoside diphosphokinase to guanine nucleotide regulation of agonist binding to formyl peptide receptors.
    Wieland T; Bremerich J; Gierschik P; Jakobs KH
    Eur J Pharmacol; 1991 Sep; 208(1):17-23. PubMed ID: 1657618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A threshold level of coupled G-proteins is required to transduce neutrophil responses.
    Omann GM; Harter JM; Hassan N; Mansfield PJ; Suchard SJ; Neubig RR
    J Immunol; 1992 Sep; 149(6):2172-8. PubMed ID: 1517577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rabbit neutrophil N-formyl peptide receptor. cDNA cloning, expression, and structure/function implications.
    Ye RD; Quehenberger O; Thomas KM; Navarro J; Cavanagh SL; Prossnitz ER; Cochrane CG
    J Immunol; 1993 Feb; 150(4):1383-94. PubMed ID: 8432984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of prenylcysteine analogues on chemoattractant receptor-mediated G protein activation.
    McLeish KR; Lederer ED; Klein JB; Hoffman JL
    Cell Signal; 1994 Jul; 6(5):569-79. PubMed ID: 7818993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L- leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E.
    Wenzel-Seifert K; Seifert R
    J Immunol; 1993 May; 150(10):4591-9. PubMed ID: 8387097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of mediators by DMSO-differentiated HL-60 cells exposed to electric interferential current and the requirement of biochemical prestimulation.
    Sontag W
    Int J Radiat Biol; 2001 Jun; 77(6):723-34. PubMed ID: 11403712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants.
    Radhika V; Thennarasu S; Naik NR; Kumar A; Advani SH; Bhisey AN
    Am J Hematol; 1996 Jul; 52(3):155-64. PubMed ID: 8756080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subsecond modulation of formyl peptide-linked guanine nucleotide-binding proteins by guanosine 5'-O-(3-thio)triphosphate in permeabilized neutrophils.
    Neubig RR; Sklar LA
    Mol Pharmacol; 1993 May; 43(5):734-40. PubMed ID: 8502230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous spectrofluorometric analysis of formyl peptide receptor ternary complex interactions.
    Posner RG; Fay SP; Domalewski MD; Sklar LA
    Mol Pharmacol; 1994 Jan; 45(1):65-73. PubMed ID: 8302282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of receptor-G protein interactions in permeabilized cells.
    Wieland T; Liedel K; Kaldenberg-Stasch S; Meyer zu Heringdorf D; Schmidt M; Jakobs KH
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):329-36. PubMed ID: 7630424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
    Tardif M; Mery L; Brouchon L; Boulay F
    J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guanine nucleotide regulatory proteins as transducers of receptor-stimulated neutrophil activation.
    Bokoch GM; Sklar LA; Smolen JE
    Int J Tissue React; 1987; 9(4):285-93. PubMed ID: 3114163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of tunicamycin on the expression and function of formyl peptide chemotactic receptors of differentiated HL-60 cells.
    Heiman DF; Gardner JP; Apfeldorf WJ; Malech HL
    J Immunol; 1986 Jun; 136(12):4623-30. PubMed ID: 3011898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.